The emergence of virulent variants that the existing vaccines don’t work against, especially in countries that are already behind on vaccinations or unable to a

The emergence of virulent variants that the existing vaccines don’t work against, especially in countries that are already behind on vaccinations or unable to acquire vaccines is a good reason to not stop research into treatments that may provide other options. I’m not making a claim that ivermectin is that treatment, but saying “who cares” goes against the old advice that “if you have one you have none, and if you have two you have one.” It’s always good to have options.